Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $24.25.
Several research analysts have issued reports on ANL shares. Weiss Ratings reiterated a "sell (e+)" rating on shares of Adlai Nortye in a report on Tuesday, July 14th. HC Wainwright boosted their price target on shares of Adlai Nortye from $16.00 to $20.00 and gave the company a "buy" rating in a report on Monday, April 20th. JonesTrading began coverage on shares of Adlai Nortye in a research report on Thursday, May 14th. They issued a "buy" rating and a $22.00 price target for the company. Oppenheimer initiated coverage on shares of Adlai Nortye in a research note on Thursday, May 28th. They set an "outperform" rating and a $32.00 price objective on the stock. Finally, Cantor Fitzgerald began coverage on shares of Adlai Nortye in a research note on Monday, June 22nd. They set an "overweight" rating on the stock.
Check Out Our Latest Analysis on Adlai Nortye
Institutional Trading of Adlai Nortye
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. SmartHarvest Portfolios LLC increased its holdings in shares of Adlai Nortye by 8.5% in the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company's stock valued at $113,000 after acquiring an additional 1,279 shares during the period. Renaissance Technologies LLC purchased a new stake in shares of Adlai Nortye during the 1st quarter worth $457,000. Affinity Asset Advisors LLC purchased a new stake in shares of Adlai Nortye during the 1st quarter worth $1,140,000. Finally, ADAR1 Capital Management LLC purchased a new stake in shares of Adlai Nortye during the 1st quarter worth $816,000. Institutional investors own 35.21% of the company's stock.
Adlai Nortye Stock Performance
Shares of Adlai Nortye stock opened at $13.23 on Tuesday. The stock's fifty day moving average price is $11.26 and its 200-day moving average price is $10.52. Adlai Nortye has a 12 month low of $0.88 and a 12 month high of $17.25.
About Adlai Nortye
(
Get Free Report)
Adlai Nortye Inc NASDAQ: ANL is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Adlai Nortye, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adlai Nortye wasn't on the list.
While Adlai Nortye currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
